150 related articles for article (PubMed ID: 861145)
1. In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.
Camplejohn RS; Schultze B; Maurer W
Br J Cancer; 1977 May; 35(5):546-56. PubMed ID: 861145
[TBL] [Abstract][Full Text] [Related]
2. Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.
Au JL; Rustum YM; Minowada J; Srivastava BI
Biochem Pharmacol; 1983 Feb; 32(3):541-6. PubMed ID: 6221728
[TBL] [Abstract][Full Text] [Related]
3. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Myers CE; Young RC; Chabner BA
Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
[TBL] [Abstract][Full Text] [Related]
4. Effect of methotrexate on the cell cycle of L1210 leukemia.
Goncharova SA; Frankfurt OS
Cell Tissue Kinet; 1976 Jul; 9(4):333-40. PubMed ID: 945129
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic efficacy of 5-fluorouracil with concurrent thymidine infusion against transplantable colon tumors in rodents.
Danhauser LL; Rustum YM
Cancer Drug Deliv; 1984; 1(4):269-82. PubMed ID: 6549560
[TBL] [Abstract][Full Text] [Related]
6. Rescue of thymidine cytotoxicity in L1210 ascites by elevated endogenous levels of deoxycytidine.
Egan EM; Sargent L; Rosowsky A; Kufe DW
Cancer Treat Rep; 1981; 65(9-10):853-60. PubMed ID: 7273018
[TBL] [Abstract][Full Text] [Related]
7. The validity of the labelling index in tumour studies.
Hamilton E; Dobbin J
Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of action of 5-FU: biochemical basis.
Rustum YM; Danhauser L; Wang G
Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
[TBL] [Abstract][Full Text] [Related]
9. Effects of 5-fluorouracil on mitotic index and incorporation of 3H-thymidine into DNA in erythropoietic mouse spleens.
Panfil B; Bitny-Szlachto S
Acta Pol Pharm; 1987; 44(2):225-9. PubMed ID: 3434316
[No Abstract] [Full Text] [Related]
10. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
Roobol C; De Dobbeleer GB; Bernheim JL
Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011
[TBL] [Abstract][Full Text] [Related]
11. Comparing cell kinetic studies of the effect of ftorafur and 5-fluorouracil on the L 1210 ascites tumor.
Schultze B; Jellinghaus W; Weis G; Müller V; Maurer W
J Cancer Res Clin Oncol; 1981; 100(1):25-40. PubMed ID: 6787060
[TBL] [Abstract][Full Text] [Related]
12. Current studies of methotrexate and 5-fluorouracil and their interaction in human tumor cells.
Tattersall MH
Semin Oncol; 1983 Jun; 10(2 Suppl 2):6-14. PubMed ID: 6867755
[TBL] [Abstract][Full Text] [Related]
13. [3H]thymidine labels less than half of the DNA-synthesizing cells in the mouse tumour, carcinoma NT.
Hamilton E; Dobbin J
Cell Tissue Kinet; 1982 Jul; 15(4):405-11. PubMed ID: 7105131
[TBL] [Abstract][Full Text] [Related]
14. Effects of 5-fluorouracil on various melanoma cell metabolisms. Its use for assessing the cold thymidine pool.
Vercammen-Grandjean AF; Arnould R; Libert A; Lejeune FJ
Anticancer Res; 1982; 2(3):133-40. PubMed ID: 7125600
[TBL] [Abstract][Full Text] [Related]
15. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
Engelbrecht C; Ljungquist I; Lewan L; Yngner T
Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
[TBL] [Abstract][Full Text] [Related]
16. Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation.
Woodcock TM; Martin DS; Damin LA; Kemeny NE; Young CW
Cancer; 1980 Mar; 45(5 Suppl):1135-43. PubMed ID: 7357508
[TBL] [Abstract][Full Text] [Related]
17. Cell surface alterations associated with exposure of leukemia L1210 cells to fluorouracil.
Kessel D
Cancer Res; 1980 Feb; 40(2):322-4. PubMed ID: 7356515
[TBL] [Abstract][Full Text] [Related]
18. Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation.
Perez DJ; Tattersall MH
Eur J Cancer Clin Oncol; 1983 Mar; 19(3):371-6. PubMed ID: 6683175
[TBL] [Abstract][Full Text] [Related]
19. The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.
Young RC; DeVita VT; Perry S
Cancer Res; 1969 Aug; 29(8):1581-4. PubMed ID: 5807231
[No Abstract] [Full Text] [Related]
20. [The metabolism of high-molecular-weight substances in cells and the effect of anticancer drugs].
Kanamaru R; Kakuta H; Sato T; Ishioka C; Konishi Y; Wakui A; Dei T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):837-44. PubMed ID: 3566294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
